MOGAD care at Mayo Clinic
Your Mayo Clinic care team
Mayo Clinic's world-renowned MOGAD teams include pediatric and adult neurologists, neuro-ophthalmologists, physical medicine and rehabilitation specialists (physiatrists), urologists and neuropsychologists, as well as other specialists working together as a multidisciplinary team to evaluate and treat everyone.
With an emphasis on collaborative care, specialists interact very closely with their colleagues across all campuses.
This collaboration means that you're not getting just one opinion — your care is discussed among the team, and the most highly specialized MOGAD experts in the world are all working together for you. Your test results are available quickly and your appointments are scheduled in coordination. What might take months to accomplish elsewhere can typically be done in only a matter of days or a few weeks at Mayo Clinic.
Advanced diagnosis and treatment
MOGAD can be difficult to diagnose, as symptoms often vary from person to person or may be caused by a different condition. An accurate diagnosis is critical to provide the most effective care.
With a concentration on MOGAD and vast experience, Mayo Clinic doctors are able to make accurate diagnoses and recommend effective treatments from the start.
Because children are more predisposed to MOGAD, access to a pediatric MOGAD expert is important. Mayo Clinic has a specialized pediatric center that is staffed by a team of experts devoted to treating children with MOGAD.
At Mayo Clinic, researchers are always working to develop new diagnostic tools and treatments to improve outcomes for people with MOGAD.
For example, Mayo Clinic was the first to develop a MOG antibody test in the United States. Mayo Clinic is enrolling patients in clinical trials for attack-prevention treatments in MOGAD.
Research
Mayo Clinic experts continually study new diagnostic and treatment options, which they test through clinical trials.
Mayo Clinic researchers were one of the earliest to receive funding from the NIH to study how common MOGAD is around the world. Mayo Clinic researchers were the first to show that MOGAD does not form scars in the brain like MS and that most lesions resolve over time. Mayo Clinic researchers were involved in the development of MOGAD diagnostic criteria. Mayo Clinic researchers also showed the potential benefit of IVIG in MOGAD. These findings may help guide clinical trials to develop a proven treatment for this disease.
Learn more about Mayo Clinic's neurosurgery and neurology departments' expertise and rankings.
The MOG Project is a nonprofit organization that raises awareness for the disease. It also uses fundraising for research and focuses on educating medical professionals, patients and caregivers.
The Mayo Clinic experience and patient stories
Our patients tell us that the quality of their interactions, our attention to detail and the efficiency of their visits mean health care like they've never experienced. See the stories of satisfied Mayo Clinic patients.
Seeking, and finding, answers, comfort, and hope
As someone affected by a rare, incurable disease, Joe Mondloch and his wife Sue are always on the lookout for new information. The autoimmune neurological condition Joe lives with has left him blind in one eye, physically disabled, and poses an ongoing threat for further damage. Called MOGAD, which stands for myelin oligodendrocyte glycoprotein associated-antibody disease, the rare, immune-mediated illness has been present in Joe’s life since February 2016, when, at the age of 55,…
Expertise and rankings
Mayo Clinic's MOGAD program has earned a national reputation as a top diagnostic and treatment center. The program is recognized for its multidisciplinary approach to patient care as well as for its advanced research into improved medicines and other treatments.
The pediatric MOGAD program at Mayo Clinic in Rochester, Minnesota, is recognized as an expert center for children with MOGAD.
Mayo Clinic in Rochester, Minnesota, is ranked among the Best Hospitals for neurology and neurosurgery and for rehabilitation by U.S. News & World Report.
Jan. 03, 2024